journal cover

Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit

Archives of Neurology

Aug 1, 1987

S DeSilvaR W Kuncl

Abstract

We report the long-term results of a therapeutic trial of prednisone in the treatment of Duchenne muscular dystrophy, comparing the age at which 16 treated patients and 38 controls lost the ability to ambulate. Survival curve analysis and group mean comparisons indicate that ambulation ...read more

Mentioned in this Paper

Locomotion
Therapeutic Agent
Teens
Wheelchair
Rectodelt
Muscular Dystrophy
Prednisone
Muscular Dystrophy, Duchenne
Ambulation
Therapeutic agent (substance)
Paper Details
References
  • References
  • Citations58
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations58
12345...

Similar Papers Found In These Feeds

Muscular Dystrophy

Muscular dystrophy refers to a range of muscle diseases caused by defects in muscle proteins, leading to death of the muscle cells, with loss of muscle tissue, and weakness. Here are the latest discoveries pertaining to this disease.

Myopathies

Myopathies are genetic or acquired disorders of skeletal muscle that lead to varying degrees of weakness, atrophy, and exercise intolerance. Here are the latest discoveries pertaining to this disease.

Related Papers

The New England Journal of Medicine

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

The New England Journal of MedicineJune 15, 1989
J R MendellJulaine M Florence
© 2020 Meta ULC. All rights reserved

Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit

Archives of Neurology

Aug 1, 1987

S DeSilvaR W Kuncl

PMID: 3632394

DOI: 10.1001/archneur.1987.00520200022012

Abstract

We report the long-term results of a therapeutic trial of prednisone in the treatment of Duchenne muscular dystrophy, comparing the age at which 16 treated patients and 38 controls lost the ability to ambulate. Survival curve analysis and group mean comparisons indicate that ambulation ...read more

Mentioned in this Paper

Locomotion
Therapeutic Agent
Teens
Wheelchair
Rectodelt
Muscular Dystrophy
Prednisone
Muscular Dystrophy, Duchenne
Ambulation
Therapeutic agent (substance)

Similar Papers Found In These Feeds

Muscular Dystrophy

Muscular dystrophy refers to a range of muscle diseases caused by defects in muscle proteins, leading to death of the muscle cells, with loss of muscle tissue, and weakness. Here are the latest discoveries pertaining to this disease.

Myopathies

Myopathies are genetic or acquired disorders of skeletal muscle that lead to varying degrees of weakness, atrophy, and exercise intolerance. Here are the latest discoveries pertaining to this disease.

Paper Details
References
  • References
  • Citations58
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations58
12345...
/papers/prednisone-treatment-in-duchenne-muscular/3632394